Skip to content

Quantitative Advantage, LLC: HMOP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Quantitative Advantage, LLC on HMOP, newest first. How the timeline and the estimate are built.

Quantitative Advantage, LLC held 45,429 HMOP shares at 2023-03-31 per its 13F-HR filed 2023-05-12.

the latest 13F is the newest step

  1. period ended2023-03-31
    13F 45,429 shares
    Change vs previous 13F +11,408 shares

    0.25% of the 13F portfolio, value $1,735,621.

    13F-HR 0001420506-23-001011 filed by Quantitative Advantage, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-12-31
    13F 34,021 shares
    Change vs previous 13F -16,285 shares

    0.2% of the 13F portfolio, value $1,277,822.

    13F-HR 0001420506-23-000653 filed by Quantitative Advantage, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2022-09-30
    13F 50,306 shares
    Change vs previous 13F -1,833 shares

    0.32% of the 13F portfolio, value $1,833,000.

    13F-HR 0001420506-22-002077 filed by Quantitative Advantage, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2022-06-30
    13F 52,139 shares
    Change vs previous 13F -8,333 shares

    0.34% of the 13F portfolio, value $1,970,000.

    13F-HR 0001420506-22-001496 filed by Quantitative Advantage, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2022-03-31
    13F 60,472 shares
    Change vs previous 13F not available

    0.36% of the 13F portfolio, value $2,372,000.

    13F-HR 0001420506-22-000997 filed by Quantitative Advantage, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).